Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Capital Group Investment Management PTE. LTD. Has $2.53 Million Stake in Royalty Pharma PLC $RPRX
Capital Group Investment Management PTE. LTD. increased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 65,513 shares of the…
TD Asset Management Inc Has $49.90 Million Position in Ascendis Pharma A/S $ASND
TD Asset Management Inc lowered its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 21.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 234,012…
Detailed data show Pfizer's monthly obesity drug continues to show potential
Detailed data from a mid-stage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly. But it's not clear how competitive the treatment would be against weekly injectables on the market…
Ellington Financial: A Diversified Mortgage REIT That Saw Q1 Loans And Earnings Grow (NYSE:EFC)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
State board students dominate CET toppers list
The results of Karnataka Common Entrance Test (CET) - 2026, the gateway for admission to professional courses including engineering, announced on Saturday, have students from state board Pre-University colleges dominating the top ranks. Students…
160 year old Cobh redbrick house and mews with waterfront views for €1.5m
Don't let your teens read this article if you're buying this Rushbrooke house in case they're ‘inspired' to get up to the same shenanigans as the ones who grew up here over the last four or more decades. The younger members of the household…
Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 10.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm…
'The Country Is Not Trump's To Liquidate': His Grift Is Costing Us All
The American Economic Liberties Project and Groundwork Collaborative on Wednesday released a joint report detailing how President Donald Trump's unprecedented corruption is padding his own pockets at the expense of US taxpayers. The…
ICICI Pru Multi Sector Passive FOF: Should You Invest In This Sector Rotation Fund?
Sector investing can look enticing, but it is also easy to get it wrong. Investors often enter a sector/theme after it has already run up, and lose patience when the cycle turns. ICICI Prudential Multi Sector Passive FoF (formerly known as ICICI…
Sarepta Therapeutics, Inc. $SRPT Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 59.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 727,786 shares of…
The Next Quantum Computing IPO CEO Just Told CNBC 'It Is Not 10 to 15 Years Out. It's Very Much Now
Quantinuum, the Honeywell-backed trapped-ion quantum computing company, began trading on the NASDAQ today after pricing its IPO at $60 per share and raising $1.68 billion. On CNBC's Squawk Box this morning, CEO Rajeeb Hazra delivered the line that…
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Bruker NASDAQ: BRKR is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping offset continued weakness in U.S. academic…
Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy
AbbVie (NYSE:ABBV - Get Free Report) was downgraded by Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a research note issued on Sunday. Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute…
Capital Group Investment Management PTE. LTD. Sells 5,421 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Capital Group Investment Management PTE. LTD. trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 20.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and…
Capital Group Private Client Services Inc. Purchases 6,065 Shares of AbbVie Inc. $ABBV
Capital Group Private Client Services Inc. boosted its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 11.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund…
Receive a Daily briefing on Pharma Industry News
Get Started